Yahoo
KSE - Delayed Quote KRW

Cosmax, Inc. (192820.KS)

247,000.00 -1,000.00 (-0.40%)
At close: October 30 at 3:30:12 PM GMT+9
Chart Range Bar
Loading chart for 192820.KS
  • Previous Close 248,000.00
  • Open 247,000.00
  • Bid 245,000.00 x --
  • Ask 244,500.00 x --
  • Day's Range 241,500.00 - 256,000.00
  • 52 Week Range 141,000.00 - 320,000.00
  • Volume 125,558
  • Avg. Volume 130,001
  • Market Cap (intraday) 2.802T
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date (est.) --
  • Forward Dividend & Yield 3,300.00 (1.34%)
  • Ex-Dividend Date Mar 30, 2026
  • 1y Target Est 316,840.00

Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong-si, South Korea.

www.cosmax.com

1,645

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

192820.KS
54.01%
KOSPI Composite Index (^KS11)
35.99%

1-Year Return

192820.KS
24.28%
KOSPI Composite Index (^KS11)
40.22%

3-Year Return

192820.KS
86.67%
KOSPI Composite Index (^KS11)
148.02%

5-Year Return

192820.KS
107.68%
KOSPI Composite Index (^KS11)
92.91%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 794.89B
Earnings 51.66B
Profit Margin 6.50%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200B
400B
600B
5.0%
10.0%
15.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

180,000.00 Low
316,840.00 Average
247,000.00 Current
430,000.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.92%

  • Return on Assets (ttm)

    5.60%

  • Return on Equity (ttm)

    32.06%

  • Revenue (ttm)

    2.66T

  • Net Income Avi to Common (ttm)

    184.27B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    337.39B

  • Total Debt/Equity (mrq)

    153.07%

  • Levered Free Cash Flow (ttm)

    -70.22B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: